Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Business Alignment PCL's Price-to-Tangible-Book or its related term are showing as below:
BKK:BIZ-R'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.57 Med: 2.69 Max: 5.2
Current: 4.13
During the past 11 years, Business Alignment PCL's highest Price to Tangible Book Ratio was 5.20. The lowest was 1.57. And the median was 2.69.
BKK:BIZ-R's Price-to-Tangible-Book is ranked worse than 66.19% of 701
companies
in the Medical Devices & Instruments industry
Industry Median: 2.66
vs BKK:BIZ-R: 4.13
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Business Alignment PCL Price-to-Tangible-Book Related Terms
Business Alignment PCL Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Business Alignment PCL's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Business Alignment PCL Price-to-Tangible-Book Chart
BKK:BIZ-R vs ABT, SYK, MDT: Price-to-Tangible-Book Comparison
For the Medical Devices subindustry, Business Alignment PCL's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Business Alignment PCL Price-to-Tangible-Book vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Business Alignment PCL's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Business Alignment PCL's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Business Alignment PCL (BKK:BIZ-R) has a Price-to-Tangible-Book of 4.13 as of Aug. 30, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Business Alignment PCL and its competitors. According to the industry distribution chart, Business Alignment PCL ranks #464 out of 701 companies in the Medical Devices & Instruments industry, placing it in the top 66.2%.
Is Business Alignment PCL's Price-to-Tangible-Book too high?
Business Alignment PCL's current Price-to-Tangible-Book is 4.13. The Medical Devices & Instruments industry median Price-to-Tangible-Book is 2.66. Business Alignment PCL's value of 4.13 is 55.3% above this industry median. Based on the distribution chart, Business Alignment PCL ranks #464 out of 701 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Business Alignment PCL has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Business Alignment PCL's Price-to-Tangible-Book compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Business Alignment PCL ranks #464 out of 701 companies for Price-to-Tangible-Book. This places Business Alignment PCL in the lower half of its industry. The industry median Price-to-Tangible-Book is 2.66. Business Alignment PCL's value of 4.13 is 55.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Devices & Instruments company?
The median Price-to-Tangible-Book among Medical Devices & Instruments companies is 2.66, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Business Alignment PCL's current Price-to-Tangible-Book of 4.13 is 55.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Business Alignment PCL and its competitors. For the Medical Devices & Instruments industry, the median Price-to-Tangible-Book is 2.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Business Alignment PCL's current Price-to-Tangible-Book is 4.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Business Alignment PCL stock overvalued right now?
Business Alignment PCL (BKK:BIZ-R) has a current Price-to-Tangible-Book of 4.13. The stock's GF Value™ is ฿5.44, compared to a current price of ฿5.95 — trading 9.4% above its estimated fair value. The current Price-to-Tangible-Book is 4.13 and 55.3% above the Medical Devices & Instruments industry median of 2.66. Business Alignment PCL's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Business Alignment PCL (BKK:BIZ-R), the current Price-to-Tangible-Book is 4.13 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Business Alignment PCL (BKK:BIZ-R) Overvalued in 2026?
Based on GuruFocus' analysis, Business Alignment PCL stock appears to be overvalued.
The current stock price of ฿5.95 is trading 9.4% above its estimated GF Value™ of ฿5.44.
Key valuation signals for BKK:BIZ-R:
Price-to-Tangible-Book: 4.13
GF Value™: ฿5.44 vs. price of ฿5.95 (9.4% above fair value)
Industry Position: 55.3% above the Medical Devices & Instruments median (#464 of 701)
No single metric tells the full story. See the BKK:BIZ-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Business Alignment PCL is engaged in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company operates through the sale of medical equipment segment which includes installation, repair, and maintenance. In addition, it also focuses on increasing the efficiency of medical equipment; and Hospital operations (specialized in cancer treatment). The company is a distributor for Radiotherapy products and Brachytheraphy products in Thailand and Cambodia. Geographically, it operates in the region of Thailand.
91GF Score
Get the complete analysis for BKK:BIZ-R
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIZ-R has been successfully added to your 
